SELP
P-selectin
Also known as: CD62, CD62P, GMP140, GRMP, LYAM3_HUMAN, PADGEM, PSEL
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P16109
- Gene
- SELP
- Ensembl
- ENSG00000174175
- Chromosome
- 1
- Canonical length
- 830 aa
- Protein class
- Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins
OverviewNCBI Gene
This gene encodes a 140 kDa protein that is stored in the alpha-granules of platelets and Weibel-Palade bodies of endothelial cells. This protein redistributes to the plasma membrane during platelet activation and degranulation and mediates the interaction of activated endothelial cells or platelets with leukocytes. The membrane protein is a calcium-dependent receptor that binds to sialylated forms of Lewis blood group carbohydrate antigens on neutrophils and monocytes. Alternative splice variants may occur but are not well documented. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
830 residues, UniProt reviewed canonical sequence.
>P16109|SELP
1 MANCQIAILY QRFQRVVFGI SQLLCFSALI SELTNQKEVA AWTYHYSTKA YSWNISRKYC
61 QNRYTDLVAI QNKNEIDYLN KVLPYYSSYY WIGIRKNNKT WTWVGTKKAL TNEAENWADN
121 EPNNKRNNED CVEIYIKSPS APGKWNDEHC LKKKHALCYT ASCQDMSCSK QGECLETIGN
181 YTCSCYPGFY GPECEYVREC GELELPQHVL MNCSHPLGNF SFNSQCSFHC TDGYQVNGPS
241 KLECLASGIW TNKPPQCLAA QCPPLKIPER GNMTCLHSAK AFQHQSSCSF SCEEGFALVG
301 PEVVQCTASG VWTAPAPVCK AVQCQHLEAP SEGTMDCVHP LTAFAYGSSC KFECQPGYRV
361 RGLDMLRCID SGHWSAPLPT CEAISCEPLE SPVHGSMDCS PSLRAFQYDT NCSFRCAEGF
421 MLRGADIVRC DNLGQWTAPA PVCQALQCQD LPVPNEARVN CSHPFGAFRY QSVCSFTCNE
481 GLLLVGASVL QCLATGNWNS VPPECQAIPC TPLLSPQNGT MTCVQPLGSS SYKSTCQFIC
541 DEGYSLSGPE RLDCTRSGRW TDSPPMCEAI KCPELFAPEQ GSLDCSDTRG EFNVGSTCHF
601 SCDNGFKLEG PNNVECTTSG RWSATPPTCK GIASLPTPGV QCPALTTPGQ GTMYCRHHPG
661 TFGFNTTCYF GCNAGFTLIG DSTLSCRPSG QWTAVTPACR AVKCSELHVN KPIAMNCSNL
721 WGNFSYGSIC SFHCLEGQLL NGSAQTACQE NGHWSTTVPT CQAGPLTIQE ALTYFGGAVA
781 STIGLIMGGT LLALLRKRFR QKDDGKCPLN PHSHLGTYGV FTNAAFDPSPLocalizationUniProt · AlphaFold · HPA
Whether an antibody against SELP can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.37
- Highest tissue expression
- 13 nTPM
Expression across tissuesHPA
Tissue
- urinary bladder: 13 nTPM
- smooth muscle: 13 nTPM
- lung: 12 nTPM
- tonsil: 12 nTPM
- appendix: 11 nTPM
- adipose tissue: 11 nTPM
Single-cell type
- platelets: 580 nCPM
- megakaryocytes: 99 nCPM
- vascular endothelial cells: 91 nCPM
- megakaryocyte progenitors: 78 nCPM
- hematopoietic stem cells: 22 nCPM
- lymphatic endothelial cells: 19 nCPM
Immune cell
- T-reg: 8.8 nTPM
- basophil: 8.2 nTPM
- total PBMC: 7.8 nTPM
- neutrophil: 2.1 nTPM
- memory B-cell: 1.1 nTPM
- eosinophil: 0.6 nTPM
Brain region
- choroid plexus: 8.2 nTPM
- thalamus: 2.3 nTPM
- basal ganglia: 1.9 nTPM
- cerebral cortex: 1.7 nTPM
- amygdala: 1 nTPM
- medulla oblongata: 0.9 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about SELP.
Disease | GeneticClinVar
1 pathogenic / likely-pathogenic of 137 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Premature coronary artery atherosclerosis
Disease | AutoantibodyPubMed
Conditions in which antibodies against SELP are reported. Each links to that disease's full target list.
ReferencesPubMed · IEDB
Publications for SELP from three distinct lines of evidence, kept separate because they answer different questions: whether antibodies are directed at the protein, whether a B-cell epitope has been mapped on it, and whether a T-cell epitope has. Each is labelled with its source.
Reference: AutoantibodyPubMed
12 publications
- Effect of fondaparinux on platelet activation in the presence of heparin-dependent antibodies: a blinded comparative multicenter study with unfractionated heparin.
2005 · Blood · RCR 4 · 152 citations - Antibody to human leukocyte antigen triggers endothelial exocytosis.
2007 · Proc Natl Acad Sci U S A · RCR 2.7 · 116 citations - Elevated Plasma P-Selectin Autoantibodies in Primary Sjögren Syndrome Patients with Thrombocytopenia.
2015 · Med Sci Monit · RCR 1.2 · 27 citations - Evaluation of a flow cytometric assay for the confirmation of heparin-induced thrombocytopenia.
2016 · Int J Lab Hematol · RCR 0.7 · 15 citations - Flow cytometric immunobead assay for quantitative detection of platelet autoantibodies in immune thrombocytopenia patients.
2017 · J Transl Med · RCR 0.6 · 11 citations
Show 7 more
- Anti-GMP140 (CD62) autoantibody in a patient with autoimmune thrombocytopenic purpura.
1994 · Br J Haematol · RCR 0.2 · 7 citations - Platelet activation in patients with antiphospholipid syndrome.
1998 · Blood Coagul Fibrinolysis · RCR 0.2 · 6 citations - In vitro effect of anti-β₂ glycoprotein I antibodies on P-selectin expression, a marker of platelet activation.
2012 · Reumatismo · RCR 0.1 · 4 citations - Association between P-Selectin Autoantibody Positive and Response to Steroid Treatment in Newly Diagnosed Immune Thrombocytopenia Patients.
2022 · Acta Haematol · RCR 0.1 · 1 citations - [Evaluation and its clinical significance of anti-platelet granule membrane protein-140 autoantibodies and anticalmodulin antibody in patients with severe pregnancy-induced hypertension].
1995 · Zhonghua Fu Chan Ke Za Zhi · RCR 0 · 1 citations - [Correlation of Plasma Co-stimulatory Molecules B7-H2 and B7-H3 with Platelet Auto-antibodies in Patients with Immune Thrombocytopenic Purpura].
2015 · Zhongguo Shi Yan Xue Ye Xue Za Zhi - Platelet functional activity in patients with immune thrombocytopenia.
2025 · Biomed Khim
Sources: PubMed — antigen-level antibody evidence from a custom retrieval. Records matching a controlled set of autoantibody terms (the MeSH descriptors Autoantibodies and Autoantigens, with title and abstract term variants) were obtained through NCBI E-utilities, and their titles and abstracts parsed for constructions that direct an antibody at a named protein rather than for co-occurrence. Captured names were resolved against UniProt nomenclature and each antigen adjudicated individually against the source text. Bibliographic records from PubMed and MeSH, U.S. National Library of Medicine; citation metrics from NIH iCite (Hutchins et al., PLoS Biology 2016). Titles link to PubMed; abstracts are not reproduced here. The NLM does not endorse this analysis.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.32
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.26
- DepMap mean gene effect
- -0.12
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules
- cell adhesion
- cell-cell adhesion
- defense response to Gram-negative bacterium
- heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules
- inflammatory response
- leukocyte cell-cell adhesion
- leukocyte tethering or rolling
- positive regulation of leukocyte migration
- positive regulation of leukocyte tethering or rolling
- positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction
- positive regulation of platelet activation
- regulation of integrin activation
- response to cytokine
- response to lipopolysaccharide
Molecular functions
- calcium ion binding
- calcium-dependent protein binding
- fucose binding
- glycosphingolipid binding
- heparin binding
- integrin binding
- lipopolysaccharide binding
- oligosaccharide binding
- sialic acid binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Sushi/SCR/CCP domain
- EGF-like domain
- C-type lectin-like
- Selectin superfamily
- C-type lectin-like/link domain superfamily
- C-type lectin fold
- C-type lectin, conserved site
- Selectin, C-type lectin-like domain
- Sushi/SCR/CCP superfamily
- Complement & Cell Adhesion Regulators
- Lectin C-type domain
- Sushi repeat (SCR repeat)
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of SELP in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads SELP as an antibody target. Whether an autoantibody or antibody against SELP could matter depends on whether native SELP is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
SELP is annotated at the cell surface, where native SELP is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label SELP as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...